Literature DB >> 30457335

Polyheteroaryl Oxazole/Pyridine-Based Compounds Selected in Vitro as G-Quadruplex Ligands Inhibit Rock Kinase and Exhibit Antiproliferative Activity.

Daniela Verga1, Chi-Hung N'Guyen1, Malika Dakir2, Jean-Luc Coll2, Marie-Paule Teulade-Fichou1, Annie Molla2.   

Abstract

Heptaheteroaryl compounds comprised of oxazole and pyridine units (TOxaPy) are quadruplex DNA (G4)-interactive compounds. Herein, we report on the synthesis of parent compounds bearing either amino side chains (TOxaPy-1-5) or featuring an isomeric oxazole-pyridine central connectivity (iso-TOxapy, iso-TOxapy 1-3) or a bipyridine core (iso-TOxabiPy). The new isomeric series showed significant G4-binding activity in vitro, and remarkably, three compounds (iso-TOxaPy, iso-TOxaPy-1, and iso-TOxabiPy) exhibited high antiproliferative activity toward a tumor panel of cancer cell lines. However, these compounds do not behave as typical G-quadruplex (G4) binders, and the kinase profiling assay revealed that the best antiproliferative molecule iso-TOxaPy selectively inhibited Rock-2. The targeting of Rock kinase was confirmed in cells by the dephosphorylation of Rock-2 substrates, the decrease of stress fibers, and peripheral focal adhesions, as well as the induction of long neurite-like extensions. Remarkably, two of these molecules were able to inhibit the growth of cells organized as spheroids.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30457335     DOI: 10.1021/acs.jmedchem.8b01023

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  2,6-Dicyano-4-pyrone as a Novel and Multifarious Building Block for the Synthesis of 2,6-Bis(hetaryl)-4-pyrones and 2,6-Bis(hetaryl)-4-pyridinols.

Authors:  Dmitrii L Obydennov; Alena E Simbirtseva; Sergey E Piksin; Vyacheslav Y Sosnovskikh
Journal:  ACS Omega       Date:  2020-12-15

2.  A DNA small molecular probe with increasing K+ concentration promoted selectivity.

Authors:  Ya-Ping Gong; Jian Yang; Ji-Wang Fang; Qian Li; Zhi-Yong Yu; Aijiao Guan; Han-Yuan Gong
Journal:  RSC Adv       Date:  2021-04-22       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.